Unity Biotechnology Inc (UBX)

Unity Biotechnology Inc (UBX) 財務データ

損益計算書

四半期ごと

*すべての数値は百万単位です

期間終了日	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	-	-	-	-	-
Operating Expenses	24.82% 14.93	11.96	10.65	13.92	13.13
Interest Income/Expense	51.99% 0.47	0.979	1.002	0.99	0.866
Operating Income/Loss	24.82% -14.93	-11.96	-10.65	-13.92	-13.13
Income/Loss From Continuing Operations Before Tax	25.27% -15.29	-12.21	-10.87	-	-13.71
Income/Loss From Continuing Operations After Tax	25.27% -15.29	-12.21	-10.87	-14.17	-13.71
Net Income/Loss	25.27% -15.29	-12.21	-10.87	-14.17	-13.71
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.20% 14.60	14.43	14.31	1.5657	10.07
Diluted Average Shares	1.20% 14.60	14.43	14.31	1.5657	10.07
Basic Earnings Per Share	23.53% -1.05	-0.85	-0.76	-0.54	-1.36
Diluted Earnings Per Share	23.53% -1.05	-0.85	-0.76	-0.54	-1.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-